entertainment -WSS

entertainment

author：explore 2025-10-01 22:49:24 - browse：222

A dosage of Wegovy, a drug used for weight loss — Amanda Andrade-Rhoades/AP

U.S. regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly popular treatment.

The new label indicates that Wegovy can be used to reduce the risk of major heart complications — including heart attack, stroke, or cardiovascular-related deaths — for people with overweight or obesity and existing heart disease, Novo said in a statement Friday.

The decision was based on results of a large, five-year trial that showed Wegovy cut the risk of cardiovascular problems by 20% in that population. This is the first time a weight loss treatment has been approved to also help improve heart outcomes, the FDA said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Does aspartame cause cancer? What new WHO guidance says

entertainment

WSS

Woman gored by Bison at Yellowstone

Study: AI not yet building 'n

Grail faces three suits alleging harassment, retaliation

Mike Pence clashes with Tucker Carlson in Iowa

Readout LOUD podcast: What to know about H5N1 bird flu

Readout LOUD podcast: brain research, obesity drug sales, Novartis

leisure time

entertainment

entertainment

Cancer drug shortages should be causing more outrage

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Moonlake's readout produced a cash windfall. Risks remain

Involuntary treatment for addiction doesn't work

As demand for Covid shots wanes, Moderna seeks its next success

Congress likely to miss an opportunity to fix drug shortages issue

The cancer drug shortage isn’t new — and neither are the solutions

Steward Health Care files for bankruptcy

Cancer drug shortages should be causing more outrage

Sanofi strikes deal with Novavax, boosting the vaccine maker

Wikipedia

Congress: Eradicate hepatitis C and reduce the deficit

H5N1 bird flu: what we're starting to learn about infection in cows

Telehealth startups turn to complex chronic diseases

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Telehealth startups turn to complex chronic diseases

Sanofi strikes deal with Novavax, boosting the vaccine maker

leisure time

knowledge

entertainment

entertainment